RE
SNOA icon

RBC Europe’s Sonoma Pharmaceuticals SNOA Stock Holding History

RBC Europe’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56
Closed -$6.21K – 1068
2021
Q3 		$6.21K Hold
56
– – ﹤0.01% 1015
2021
Q2 		$8.16K Hold
56
– – ﹤0.01% 992
2021
Q1 		$8.26K Hold
56
– – ﹤0.01% 943
2020
Q4 		$8.07K Hold
56
– – ﹤0.01% 910
2020
Q3 		$9.31K Buy
+56
New +$8.62K ﹤0.01% 811
2020
Q2 		– Hold
0
– – – 1060
2020
Q1 		– Hold
0
– – – 1039
2019
Q4 		– Hold
0
– – – 1049
2019
Q3 		– Hold
0
– – – 1050
2019
Q2 		– Hold
0
– – – 1062
2019
Q1 		– Hold
0
– – – 1075
2018
Q4 		– Hold
0
– – – 1089
2018
Q3 		– Hold
0
– – – 1125
2018
Q2 		– Hold
0
– – – 1132
2018
Q1 		– Hold
0
– – – 1106
2017
Q4 		– Hold
0
– – – 1114
2017
Q3 		– Hold
0
– – – 1119

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HFS
HBC Financial Services Seattle, Washington $163M AUM 14.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

RBC Europe's SNOA Position: Q4 2021 in Review

RBC Europe sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2021, closing a stake of 56 shares — an estimated $6.21K sold.

RBC Europe first reported a position in SNOA in Q3 2020 and held it in 5 quarters. The position peaked at $9.31K in Q3 2020. 18 funds tracked by Wall St. Rank hold SNOA as of Q4 2021.

  • RBC Europe reported no remaining Sonoma Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 56 Sonoma Pharmaceuticals shares in Q4 2021, an estimated $6.21K.
  • RBC Europe first reported a position in Sonoma Pharmaceuticals in Q3 2020 and held it in 5 quarters.
  • RBC Europe's Sonoma Pharmaceuticals position peaked at $9.31K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.